Cardio Diagnostics Holdings is trading at $2.20, 10.72% up in pre-market, with no clear company-specific catalyst identified.
- The stock closed at $1.99 on August 17, 2026; no major announcement dated August 18, 2026 was identified.
- Investors may be watching the scheduled August 20 investor call on commercially available tests, reimbursement progress, studies, and strategic growth initiatives, though it does not directly explain the move.
- The gain follows volatile sessions, including an 18.03% rise on August 12; volume and activity details were unavailable.